These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26284192)

  • 1. Focus on PTEN Regulation.
    Bermúdez Brito M; Goulielmaki E; Papakonstanti EA
    Front Oncol; 2015; 5():166. PubMed ID: 26284192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and modulation of PTEN activity.
    Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
    Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions.
    Liu T; Wang Y; Wang Y; Chan AM
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31454965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets.
    Liu J; Pan Y; Liu Y; Wei W; Hu X; Xin W; Chen N
    J Cell Physiol; 2023 Aug; 238(8):1693-1715. PubMed ID: 37334436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to control phosphoinositides and to analyze PTEN function in living cells using voltage sensitive phosphatases.
    Mavrantoni A; Thallmair V; Leitner MG; Schreiber DN; Oliver D; Halaszovich CR
    Front Pharmacol; 2015; 6():68. PubMed ID: 25873899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into PTEN regulation mechanisms and its potential function in targeted therapies.
    Zhang P; Chen JH; Guo XL
    Biomed Pharmacother; 2012 Oct; 66(7):485-90. PubMed ID: 22902055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells.
    Shim JH; Kim YS; Bahk YY
    Proteomics; 2006 Jan; 6(1):81-93. PubMed ID: 16294307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.
    Stiles BL
    Int J Biochem Cell Biol; 2009 Apr; 41(4):757-61. PubMed ID: 18950730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing PTEN Subcellular Localization.
    Gil A; López JI; Pulido R
    Methods Mol Biol; 2016; 1388():169-86. PubMed ID: 27033077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN is recruited to specific microdomains of the plasma membrane during lactacystin-induced neuronal apoptosis.
    Choy MS; Bay BH; Cheng HC; Cheung NS
    Neurosci Lett; 2006 Sep; 405(1-2):120-5. PubMed ID: 16857313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into PTEN.
    Tamguney T; Stokoe D
    J Cell Sci; 2007 Dec; 120(Pt 23):4071-9. PubMed ID: 18032782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders.
    Kreis P; Leondaritis G; Lieberam I; Eickholt BJ
    Front Mol Neurosci; 2014; 7():23. PubMed ID: 24744697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
    Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
    Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
    Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
    Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN: Multiple Functions in Human Malignant Tumors.
    Milella M; Falcone I; Conciatori F; Cesta Incani U; Del Curatolo A; Inzerilli N; Nuzzo CM; Vaccaro V; Vari S; Cognetti F; Ciuffreda L
    Front Oncol; 2015; 5():24. PubMed ID: 25763354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN: Tumor Suppressor and Metabolic Regulator.
    Chen CY; Chen J; He L; Stiles BL
    Front Endocrinol (Lausanne); 2018; 9():338. PubMed ID: 30038596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.
    Chen JH; Zhang P; Chen WD; Li DD; Wu XQ; Deng R; Jiao L; Li X; Ji J; Feng GK; Zeng YX; Jiang JW; Zhu XF
    Autophagy; 2015; 11(2):239-52. PubMed ID: 25701194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.